A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Condition:   Rhinovirus
Interventions:   Drug: BTA798;   Drug: Placebo
Sponsor:   Biota Scientific Management Pty Ltd
Recruiting – verified September 2010

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.